2017.5.11 The activation mechanism and drug discovery of G-protein-coupled receptors

2019-07-07 00:42:09

北京大学定量生物学中心

学术报告

 

题 目: The activation mechanism and drug discovery of G-protein-coupled receptors

报告人: 袁曙光 博士

     瑞士联邦理工学院,瑞士Actelion制药公司

 

时 间: 2017-5-11 (周四), 13:00-14:00

地 点: 北京大学老化学楼东配楼一层101报告厅

主持人: 宋晨 研究员

摘要:

More than 800 human GPCRs allow the selective detection of extracellular signals as diverse as photons, odorants, flavors, nucleotides, hormones, neurotransmitters – revealing GPCRs fundamental role in signal transduction. As they regulate many central physiological processes and are thus implicated in many diseases, GPCRs are among the most important targets for modern medicines. In spite of this medical importance and the recent progress in elucidating the 3D structures of various GPCRs, central questions how these receptors recognize extracellular chemical signals and transfer them across the cellular membrane to finally evoke an intracellular response are largely unresolved at a molecular level, mainly because the different steps during signal transmission are not directly accessible by experiments. In this context we are concentrating on central questions of GPCR mediated cellular signalling using computer based molecular dynamics simulations. Our work revealed for the first time, in atomic detail, the entire process of transmembrane signalling of various GPCRs: we found that ligand binding induces a series of conformational changes within a GPCR which opened a gate inside the receptor for water molecules entering the internal region of the receptor and subsequently driving conformational switches within the receptor which finally led to the activation of a G protein on the intracellular side of the receptor. We have applied our findings successfully to various GPCR targeted drug discovery projects.

Reference

1. Chan H.C., Li J., Stevens R.*, Yuan S.*, Trends in Pharmacological Sciences (2017).

2.S. Yuan*, Q. Peng, K. Palczewski, H. Vogel, S. Filipek*, Mechanistic Studies on the Stereoselectivity of the Serotonin 5-HT1A Receptor. Angew Chem Int Ed Engl(2016); (10.1002/anie.201603766).

3.S. Yuan*, S. Chan, H. Vogel, S. Filipek, R. C. Stevens*, K. Palczewski*, The Molecular Mechanism of P2Y1 Receptor Activation. Angew Chem Int Ed Engl (2016); (10.1002/anie.201605147R1).

4.S. Yuan*, K. Palczewski, Q. Peng, M. Kolinski, H. Vogel, S. Filipek, The mechanism of ligand-induced activation or inhibition of mu- and kappa-opioid receptors. Angew Chem Int Ed Engl 54, 7560-7563 (2015); (10.1002/anie.201501742).

5.S. Yuan*, Z. Hu, S. Filipek, H. Vogel*, W246 Opens a Gate for a Continuous Intrinsic Water Pathway during Activation of the Adenosine A Receptor. Angew Chem Int Ed Engl 54, 556-559 (2014); (10.1002/anie.201409679).

6.S. Yuan*, S. Filipek, K. Palczewski, H. Vogel*, Activation of G-protein-coupled receptors correlates with the formation of a continuous internal water pathway. Nature Communications 5, 4733 (2014)10.1038/ncomms5733).

报告人简介:

袁曙光,2009年硕士毕业于中国科学院上海有机化学研究所。之后获得欧盟玛丽居里奖学金资助,先后在比利时鲁汶大学,波兰科学院和洛桑瑞士联邦理工学院共同完成博士研究。2013年6月,袁曙光被授予最佳博士论文奖。之后袁博士获得玛丽居里瑞士联邦理工学院(ETH)博士后奖学金。2014年3月至今,袁博士加入瑞士第三大制药公司Actelion,从事计算机辅助药物设计工作。